Metabolic reprogramming and its clinical implication for liver cancer. Yang F, Hilakivi-Clarke L, Shaha A, Wang Y, et al. Hepatology 2023;78:1602-1624.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yang F, Hilakivi-Clarke L, Shaha A, Wang Y, et al. Metabolic reprogramming and its clinical implication for liver cancer. Hepatology 2023;78:1602-1624.
PMID: 36626639